These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 23426819)

  • 1. Increased growth hormone receptor (GHR) degradation due to over-expression of cytokine inducible SH2 domain-containing protein (CIS) as a cause of GH transduction defect (GHTD).
    Gil AP; Kostopoulou E; Karageorgou I; Kamzelas K; Spiliotis BE
    J Pediatr Endocrinol Metab; 2012; 25(9-10):897-908. PubMed ID: 23426819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
    Kostopoulou E; Rojas Gil AP; Spiliotis BE
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR) involvement in successful growth hormone (GH) signaling in GH transduction defect.
    Kostopoulou E; Rojas-Gil AP; Karvela A; Spiliotis BE
    J Pediatr Endocrinol Metab; 2017 Feb; 30(2):221-230. PubMed ID: 28099130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect.
    Kostopoulou E; Rojas Gil AP; Spiliotis BE
    Ann Pediatr Endocrinol Metab; 2018 Dec; 23(4):204-209. PubMed ID: 30599481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.
    Landsman T; Waxman DJ
    J Biol Chem; 2005 Nov; 280(45):37471-80. PubMed ID: 16154995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: A milk trait-associated polymorphism in the bovine growth hormone receptor gene does not affect receptor signaling.
    Zhou Y; Jiang H
    J Dairy Sci; 2006 May; 89(5):1761-4. PubMed ID: 16606747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal kinetics of growth hormone receptor signaling in single cells using FRET microscopy.
    Biener-Ramanujan E; Ramanujan VK; Herman B; Gertler A
    Growth Horm IGF Res; 2006 Aug; 16(4):247-57. PubMed ID: 16950496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in growth hormone receptor signaling.
    Rosenfeld RG; Belgorosky A; Camacho-Hubner C; Savage MO; Wit JM; Hwa V
    Trends Endocrinol Metab; 2007; 18(4):134-41. PubMed ID: 17391978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of rhGH on JAK2-STAT3 signal pathway after GHR was down-regulated by siRNA in gastric cancer cell].
    Ran G; Lin Y; Cao P; Cai XT; Li SY
    Yao Xue Xue Bao; 2013 Mar; 48(3):435-40. PubMed ID: 23724661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum-associated degradation of growth hormone receptor in Janus kinase 2-deficient cells.
    Loesch K; Deng L; Wang X; He K; Jiang J; Frank SJ
    Endocrinology; 2007 Dec; 148(12):5955-65. PubMed ID: 17761766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D; Arumugam R; Freemark M
    Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
    Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
    Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage.
    Cowan JW; Wang X; Guan R; He K; Jiang J; Baumann G; Black RA; Wolfe MS; Frank SJ
    J Biol Chem; 2005 May; 280(19):19331-42. PubMed ID: 15743767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells.
    Manabe N; Kubota Y; Kitanaka A; Ohnishi H; Taminato T; Tanaka T
    Leuk Res; 2006 Nov; 30(11):1391-8. PubMed ID: 16650892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling.
    Maamra M; Milward A; Esfahani HZ; Abbott LP; Metherell LA; Savage MO; Clark AJ; Ross RJ
    J Endocrinol; 2006 Feb; 188(2):251-61. PubMed ID: 16461551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.
    Rowlinson SW; Yoshizato H; Barclay JL; Brooks AJ; Behncken SN; Kerr LM; Millard K; Palethorpe K; Nielsen K; Clyde-Smith J; Hancock JF; Waters MJ
    Nat Cell Biol; 2008 Jun; 10(6):740-7. PubMed ID: 18488018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.